Latest News
Conference Coverage
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1a
The PARADIGMS study is the first international controlled trial to test fingolimod in pediatric patients.
From the Journals
APOE4: Elders with allele benefit from lifestyle changes
Interventions included nutrition and physical exercise information, cognitive training, and “regular health advice.”
Feature
Expert advice for the corporate titans taking on health care
Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. want to disrupt health care.
Latest News
Health care gets little attention in State of the Union address
It’s anyone’s guess as to how Mr. Trump might lower drug costs.
Conference Coverage
Study finds rising use of newer DMTs in pediatric-onset MS
Newer disease-modifying therapies often used in pediatric-onset MS patients appear to have short-term side effect profiles similar to those in...
Conference Coverage
Late thrombectomy for stroke has low number needed to treat for benefit
LOS ANGELES – The number needed to treat varied according to the level of functional outcome achieved.
Conference Coverage
Atrial fibrosis weighed as key arrhythmia, stroke trigger
Extensive left atrial fibrosis was linked with a fourfold higher stroke risk, and ablative fibrosis isolation enhanced atrial fibrillation control...
Conference Coverage
Heart attacks bring 12 weeks of higher stroke risk
During the 12 weeks following hospitalization for a myocardial infarction, patients had an elevated risk for a new-onset acute ischemic stroke.
Conference Coverage
Cerebrospinal tract may help decide mild stroke treatment
The findings could help select patients for treatment with alteplase.
Conference Coverage
APOE4 may drive tau deposition in Alzheimer’s
The finding could offer an explanation for differences in memory loss in Alzheimer’s disease.
From the Journals
Sleep improved with urinary incontinence treatment
There may be another benefit to daily antimuscarinic therapy for urgency urinary incontinence.